Safety, tolerability and pharmacokinetics of fesoterodine in patients with hepatic impairment

Sachse R1, Krastev Z2, Mateva L2, Gatchev E3, de Mey C4, Cawello W1, Horstmann R1 1. Department of Clinical Pharmacology, Schwarz Biosciences, Monheim, Germany, 2. Department Hepatology, Sofia University, Bulgaria, 3. Department Clinical Pharmacology, Sofia University, Bulgaria, 4. ACPS, Mainz-Kastel, Germany

Abstract Category

Pharmacology: Clinical

Abstract 585
Read By Title:
Scientific Non Discussion Abstract Session 21
Links

Abstract

29/03/2024 07:48:19